{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/0169-5307#drug","name":"RIVFLOZA","alternateName":"nedosiran","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"0169-5307"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA215842"},{"@type":"PropertyValue","propertyID":"UNII","value":"EGR9KYM536"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"ace9d4bc-4d20-4beb-9e9d-888690424833"}],"activeIngredient":"NEDOSIRAN SODIUM","administrationRoute":["SUBCUTANEOUS"],"dosageForm":"INJECTION, SOLUTION","manufacturer":{"@type":"Organization","name":"Novo Nordisk"},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA215842","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ace9d4bc-4d20-4beb-9e9d-888690424833","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0169-5307"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-01T20:02:04.278Z"}}